Table 1.
Factors/Subjects | Ki67 | IL-1 | IL-4 | IL-6 | IL-8 | IL-10 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
E | E | CT | E | CT | E | CT | E | CT | E | CT | |
1. | ++/+++ | +/++ | + | +++ | ++ | +++ | ++ | ++/+++ | +++ | +++ | +++ |
2. | 0/+ | +++ | ++ | +++ | ++ | ++++ | ++ | +++ | +++ | +++ | +++ |
3. | 0/+ | + | ++ | ++ | ++ | +/++ | 0 | 0 | 0 | +/++ | + |
4. | 0 | 0 | +/++ | + | + | 0 | ++ | ++ | +/++ | + | + |
5. | ++/+++ | ++ | +++ | + | +++ | ++ | +++ | 0 | ++ | ++ | +++ |
6. | ++ | +++ | ++ | ++ | +++ | +++ | +++ | ++ | ++ | +++ | ++ |
7. | ++ | +++ | ++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | ++ |
8. | ++/+++ | +++ | ++ | +++ | +++ | +++ | +++ | +/++ | ++ | +++ | ++ |
9. | +++ | +++ | ++ | +++ | +++ | +++ | +++ | 0 | ++ | +++ | ++ |
10. | ++/+++ | ++++ | ++ | +++ | +++ | +++ | +++ | 0 | + | ++++ | +++ |
11. | 0/+ | +/++ | ++ | + | + | +/++ | ++ | 0/+ | ++/+++ | ++ | ++ |
12. | ++ | +++ | ++ | +++ | + | +++ | +++ | ++ | ++ | +++ | ++ |
13. | 0/+ | ++ | ++ | 0 | + | +/++ | ++ | 0 | + | ++ | ++ |
14. | ++ | +++ | +++ | +++ | +++ | ++/+++ | +++ | 0/+ | +++ | ++/++ | +++ |
15. | ++ | ++ | ++ | ++ | ++ | ++ | ++ | +/++ | +++ | ++ | ++ |
16. | +/++ | +++ | ++ | +++ | ++ | ++ | +++ | +/++ | +++ | ++ | +/++ |
Subjects common | ++ * | ++/+++ * | ++ | Var ++/+++ | ++ * | +++ | +++ | Var +-+++ * | ++/+++ | ++/+++ * | ++ * |
Control | 0 | + | ++ | ++ | + | +/++ | ++ | +/++ | ++ | + | + |
Abbreviations: E—epithelium; CT—connective tissue; Ki67—proliferation marker; IL-1—interleukin 1; IL-4—interleukin 4; IL-6—interleukin 6; IL-8—interleukin 8; IL-10—interleukin 10; 0/+—occasional positive structures, +—few positive structures, +/++—few to moderate number of positive structures, ++—moderate number of positive structures, ++/+++—moderate to numerous positive structures, +++—numerous positive cells, +++/++++—numerous to abundant structures, ++++—abundance of positive structures in the visual field; Var—variable appearance of positive structures; * statistically significant difference of the relative number in structures between the subjects and controls.